Silence Therapeutics plc
SLNCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45,309 | -$50,310 | -$47,368 | -$45,856 |
| Dep. & Amort. | $336 | $498 | $482 | $427 |
| Deferred Tax | $0 | $0 | $0 | $4,411 |
| Stock-Based Comp. | $16,307 | $13,050 | $10,252 | $8,632 |
| Change in WC | -$33,023 | -$11,662 | -$8,263 | $38,845 |
| Other Non-Cash | -$5,951 | $3,115 | -$559 | $347 |
| Operating Cash Flow | -$67,640 | -$39,350 | -$45,456 | $6,806 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$211 | -$45 | -$440 | -$1,334 |
| Net Acquisitions | $0 | $0 | $0 | -$10,000 |
| Inv. Purchases | -$139,167 | -$20,666 | -$16,125 | $10,000 |
| Inv. Sales/Matur. | $117,412 | $36,183 | $0 | $10,000 |
| Other Inv. Act. | $0 | $958 | $23 | $10 |
| Investing Cash Flow | -$21,966 | $16,430 | -$16,542 | $8,676 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$174 | -$190 | -$211 |
| Stock Issued | $142,087 | $25,329 | $43,239 | $30,922 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $222 | $43,239 | $30,922 |
| Financing Cash Flow | $142,087 | $25,155 | $43,049 | $30,711 |
| Forex Effect | $60 | -$3,020 | $228 | -$105 |
| Net Chg. in Cash | $52,541 | -$785 | -$18,721 | $46,088 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $68,789 | $54,816 | $73,537 | $27,449 |
| End Cash | $121,330 | $54,031 | $54,816 | $73,537 |
| Free Cash Flow | -$67,851 | -$39,395 | -$45,896 | $5,472 |